EASD 2026
September 28, 2026 - October 2, 2026
Milan, Italy
Nordic Bioscience will attend this year’s EASD taking place from 28 September – 02 October in Milan, Italy. Organized by the European Association for the Study of Diabetes, this conference will revolve around diabetes, which is why we will present how our biomarkers can be applied in this area.
Our team will present three short oral presentations together with the Steno Diabetes Center Copenhagen, featuring our circulating biomarkers.
Presentation overview
| Identifier | Presentation title | Session | Presenter | Presentation time and location |
| 1160 | Endotrophin, a fibro-inflammatory biomarker, is independently associated with cardiovascular autonomic neuropathy in type 2 diabetes. | SO 117 – Glucose variability and other risk factors for cardiac autonomic neuropathy | Jens Buciek | Wednesday, 30 September, 11:45 – 12:45 (Short Oral Event C) |
| 630 | VICM, a biomarker of macrophage-driven inflammation, as a risk marker of diabetic kidney disease progression in individuals with type 2 diabetes. | SO 048 – Immunometabolism and Inflammation | Alexandra Møller | Thursday, 1 October, 14:00-15:00 (Short Oral Event F) |
| 1281 | Endotrophin as a novel fibro-inflammatory risk marker of complications in type 1 diabetes. | SO 132 – Type 1 diabetes and complications | Alexandra Møller | Thursday, 1 October, 14:00-15:00 (Short Oral Event F) |
We invite you to come by and join our presentations to learn more about our biomarkers for diabetes.
